Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate

QJM: An International Journal of Medicine

Volumn 94, Issue 1, 2001, Pages 31-37

  Armstrong, V L ^a   Wiggam, M I ^a   Ennis, C N ^a   Sheridan, B ^a   Traub, A I ^a   Atkinson, A B ^a   Bell, P M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DIANE; GLUCOSE; GONADORELIN AGONIST; INSULIN; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; SAMPLE; SYMPTOM;

EID: 0035138810     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/94.1.31     Document Type: Article

References (33)

1. Characterisation of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and or hyperinsulinaemia
2. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome
3. Women with polycystic ovary syndrome with wedge resection in 1956-1965: A long term follow up focusing on natural history and circulating hormones
4. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings
5. Associations between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects
6. The influence of androgens on insulin resistance
7. Polycystic ovary syndrome and the androgen insulin connection
8. Induction of insulin resistance by androgens and oestrogens
9. Decrease in ovarian cytochrome P450c 17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
10. Insulin resistance, secretion and metabolism in users of oral contraceptives
11. A comparison of the effects of low and conventional dose thiazide diuretics on insulin action in hypertensive patients with non-insulin-dependent diabetes
12. Influence of growth hormone on glucose-6-phosphate cycle and insulin action in normal humans
13. Measurement of size and turnover rate of body glucose pool by the isotope dilution method
14. 14 glucose
15. Algorithms for the study of episodic hormone secretion
16. Body fat distribution and peripheral insulin sensitivity in healthy men: Role of insulin pulsatility
17. Insulin Resistance; A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease
18. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome
19. Obesity, lipids, cardiovascular risk and androgen excess
20. The independent effects of hyperandrogenaemia, hyperinsulinaemia and obesity in lipid and lipoprotein profiles in women
21. Results of a one year open study with Diane-35 in women with polycystic ovary syndrome
22. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in polycystic ovary syndrome
23. No change of peripheral insulin resistance in polycystic ovary syndrome after reduction of endogenous androgens by leuprolide
24. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action women
25. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome
26. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism
27. Hormonal responses to physical exercise in patients with polycystic ovarian syndrome
28. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
29. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
30. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome
31. Pulsatile insulin has a greater hypoglycaemic effect than continuous delivery
32. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: Importance of pulse frequency
33. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes